Coronavirus (SARS-CoV) Recruiting Phase 4 Trials for AstraZeneca COVID-19 Vaccine (DB15656)

Back to Coronavirus (SARS-CoV)

Also known as: Severe Acute Respiratory Syndrome / SARS-CoV Infection / SARS Virus / SARS / Sar / Severe acute respiratory syndrome (disorder) / Severe acute respiratory syndrome NOS

Indication	Status	Phase
DBCOND0038241 (Coronavirus (SARS-CoV))	Recruiting	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04760132	National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE)	Other	AstraZeneca COVID-19 Vaccine (DB15656) Moderna COVID-19 Vaccine (DB15654) Pfizer-BioNTech COVID-19 Vaccine (DB15696)